Collen Hanlon

Dr. Colleen Hanlon is a neuroscientist and global leader in non-invasive neuromodulation therapies for substance use disorders. As Vice President of Global Medical Affairs at BrainsWay, she leads clinical trials, regulatory affairs, and scientific strategy. As a tenured professor at MUSC and Wake Forest School of Medicine, she conducted pioneering research on brain stimulation for addiction. She has authored over 100 publications and mentored 75+ trainees. In 2023, she received the International Brain Stimulation Early Career Investigator Award. Dr. Hanlon holds a Ph.D. from Duke University and is dedicated to advancing brain stimulation education and clinical translation worldwide.